Stock Events

Stock Events

Karyopharm Therapeutics (KPTI) Q3 2024 Earnings

6AugConfirmed

Q3 2023

Q4 2023

Q2 2024

Q3 2024

-0.36

-0.31

-0.25

-0.2

Details

Expected EPS

-0.297857

Actual EPS

-0.2

Surprise EPS

0.1

Surprise Percent

+32.85%

Description

Karyopharm Therapeutics (KPTI) has reported earnings of -0.2 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.